|Bid||241.51 x 1000|
|Ask||247.26 x 800|
|Day's range||244.02 - 247.10|
|52-week range||198.64 - 258.45|
|Beta (5Y monthly)||0.57|
|PE ratio (TTM)||24.25|
|Earnings date||01 Aug 2022 - 05 Aug 2022|
|Forward dividend & yield||7.76 (3.25%)|
|Ex-dividend date||16 May 2022|
|1y target est||250.03|
In the latest trading session, Amgen (AMGN) closed at $243.51, marking a -0.55% move from the previous day.
Amgen (AMGN) closed the most recent trading day at $244.85, moving -0.21% from the previous trading session.
Let's look at two companies that fit the bill: Amgen (NASDAQ: AMGN) and Microsoft (NASDAQ: MSFT). Biotech Amgen has been around since 1980, and in that time the company has survived several recessions. In the first quarter, Amgen's revenue increased by a respectable 6% year over year to $6.2 billion.